Circulation, Vol 90, 2780-2785, Copyright © 1994 by American Heart Association
E Loh, JS Stamler, JM Hare, J Loscalzo and WS Colucci
BACKGROUND: Pulmonary vascular resistance (PVR) is frequently elevated in
patients with advanced heart failure. Nitric oxide (NO), which contributes
to the activity of endothelium-derived relaxing factor, causes relaxation
of pulmonary arteries and veins in vitro. Inhalation of NO gas causes
pulmonary vasodilation in patients with primary and secondary forms of
pulmonary hypertension. METHODS AND RESULTS: To test the hypothesis that
inhalation of NO gas lowers PVR in patients with heart failure, we studied
the hemodynamic effects of a 10-minute inhalation of NO (80 ppm) in 19
patients with New York Heart Association class III (n = 5) and class IV (n
= 14) heart failure due to left ventricular (LV) dysfunction. Although
inhalation of NO had no effect on pulmonary artery pressures, the PVR
decreased by 31 +/- 7% (P < .001) due to a 23 +/- 7% increase (P <
.001) in pulmonary artery wedge pressure and despite a 4 +/- 2% (P <
.05) decrease in cardiac index. The magnitude of the decrease in PVR with
inhaled NO was inversely related (r = -.713; P < .001) to the baseline
PVR. Inhaled NO had no effect on heart rate, systemic arterial pressure,
systemic vascular resistance, or LV peak +dP/dt or -dP/dt. CONCLUSIONS: In
patients with heart failure due to LV dysfunction, inhalation of NO causes
a decrease in the PVR associated with an increase in LV filling pressure.
These findings predict that inhaled NO, if used alone at this dose (80
ppm), may have adverse effects in patients with LV failure.
ARTICLES
Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction
Department of Medicine, Brigham and Women Hospital, Boston, MA 02115.
This article has been cited by other articles:
 |
|
 |
|
  M. M. Hoeper, J. A. Barbera, R. N. Channick, P. M. Hassoun, I. M. Lang, A. Manes, F. J. Martinez, R. Naeije, H. Olschewski, J. Pepke-Zaba, et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S85 - S96. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Giardini, A. Balducci, S. Specchia, G. Gargiulo, M. Bonvicini, and F. M. Picchio Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients Eur. Heart J., July 1, 2008; 29(13): 1681 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kumar, B. G. Branch, C. B. Pattillo, J. Hood, S. Thoma, S. Simpson, S. Illum, N. Arora, J. H. Chidlow Jr., W. Langston, et al. Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis PNAS, May 27, 2008; 105(21): 7540 - 7545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Schuster, R. Alouidor, and E. S. Barquist Nonventilatory Interventions in the Acute Respiratory Distress Syndrome J Intensive Care Med, January 1, 2008; 23(1): 19 - 32. [Abstract] [PDF]
|
|
|
|
 |
|
 G. D. Lewis, J. Lachmann, J. Camuso, J. J. Lepore, J. Shin, M. E. Martinovic, D. M. Systrom, K. D. Bloch, and M. J. Semigran Sildenafil Improves Exercise Hemodynamics and Oxygen Uptake in Patients With Systolic Heart Failure Circulation, January 2, 2007; 115(1): 59 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Gaston Summary: systemic effects of inhaled nitric oxide. Proceedings of the ATS, January 1, 2006; 3(2): 170 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J.D. Griffiths and T. W. Evans Inhaled Nitric Oxide Therapy in Adults N. Engl. J. Med., December 22, 2005; 353(25): 2683 - 2695. [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Lepore, A. Maroo, L. M. Bigatello, G. W. Dec, W. M. Zapol, K. D. Bloch, and M. J. Semigran Hemodynamic Effects of Sildenafil in Patients With Congestive Heart Failure and Pulmonary Hypertension: Combined Administration With Inhaled Nitric Oxide Chest, May 1, 2005; 127(5): 1647 - 1653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Inglessis and M. J. Semigran Does inhaled nitric oxide support the hemodynamic of spontaneous breathing patients with cardiogenic shock related to right ventricular myocardial infarction? Reply J. Am. Coll. Cardiol., March 15, 2005; 45(6): 965 - 966. [Full Text] [PDF]
|
|
|
|
|
|
I. Inglessis, J. T. Shin, J. J. Lepore, I. F. Palacios, W. M. Zapol, K. D. Bloch, and M. J. Semigran Hemodynamic effects of inhaled nitric oxide in right ventricular myocardial infarction and cardiogenic shock J. Am. Coll. Cardiol., August 18, 2004; 44(4): 793 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ichinose, J. D. Roberts Jr, and W. M. Zapol Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator: Current Uses and Therapeutic Potential Circulation, June 29, 2004; 109(25): 3106 - 3111. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Wauthy, S. Abdel Kafi, W. J. Mooi, R. Naeije, and S. Brimioulle Inhaled nitric oxide versus prostacyclin in chronic shunt-induced pulmonary hypertension J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1434 - 1441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Lowson Nitric Oxide Signaling and Clinical Alternatives to Nitric Oxide Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2003; 7(3): 239 - 252. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Natori, N. Hasebe, Y.-T. Jin, T. Matsusaka, A. Ido, H. Matsuhashi, T. Ihara, and K. Kikuchi Inhaled Nitric Oxide Modifies Left Ventricular Diastolic Stress in the Presence of Vasoactive Agents in Heart Failure Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 895 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sablotzki, T. Hentschel, E. Gruenig, S. Schubert, I. Friedrich, J. Muhling, M. G. Dehne, and E. Czeslick Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance Eur. J. Cardiothorac. Surg., November 1, 2002; 22(5): 746 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Michelakis, W. Tymchak, D. Lien, L. Webster, K. Hashimoto, and S. Archer Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension: Comparison With Inhaled Nitric Oxide Circulation, May 21, 2002; 105(20): 2398 - 2403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Moya, A. J. Gow, T. J. McMahon, E. J. Toone, I. M. Cheifetz, R. N. Goldberg, and J. S. Stamler S-nitrosothiol repletion by an inhaled gas regulates pulmonary function PNAS, April 18, 2001; (2001) 91109498. [Abstract] [Full Text]
|
|
|
|
|
|
B. A. Cockrill, R. M. Kacmarek, M. A. Fifer, L. M. Bigatello, L. C. Ginns, W. M. Zapol, and M. J. Semigran Comparison of the Effects of Nitric Oxide, Nitroprusside, and Nifedipine on Hemodynamics and Right Ventricular Contractility in Patients With Chronic Pulmonary Hypertension Chest, January 1, 2001; 119(1): 128 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Krasuski, J. J. Warner, A. Wang, J. K. Harrison, V. F. Tapson, and T. M. Bashore Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2204 - 2211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Moraes, W. S. Colucci, and M. M. Givertz Secondary Pulmonary Hypertension in Chronic Heart Failure : The Role of the Endothelium in Pathophysiology and Management Circulation, October 3, 2000; 102(14): 1718 - 1723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Givertz, W. S. Colucci, T. H. LeJemtel, S. S. Gottlieb, J. M. Hare, M. T. Slawsky, C. V. Leier, E. Loh, J. M. Nicklas, and B. E. Lewis Acute Endothelin A Receptor Blockade Causes Selective Pulmonary Vasodilation in Patients With Chronic Heart Failure Circulation, June 27, 2000; 101(25): 2922 - 2927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Krieg, T. Wahlers, W. Giess, R. Rohde, M. Hartrumpf, M. Bund, and A. Haverich Inhaled nitric oxide and inhaled prostaglandin E1: effect on left ventricular contractility when used for treatment of experimental pulmonary hypertension Eur. J. Cardiothorac. Surg., November 1, 1999; 14(5): 494 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Schmid, C. Burki, M. H. C. Engel, D. Schmidlin, M. Tornic, and B. Seifert Inhaled Nitric Oxide Versus Intravenous Vasodilators in Severe Pulmonary Hypertension After Cardiac Surgery Anesth. Analg., November 1, 1999; 89(5): 1108 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S Hayward, R. P Kelly, and P. S Macdonald Inhaled nitric oxide in cardiology practice Cardiovasc Res, August 15, 1999; 43(3): 628 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Loh, E. B. Lankford, D. J. Polidori, E. B. Doering-Lubit, C. W. Hanson, and M. A. Acker Cardiovascular effects of inhaled nitric oxide in a canine model of cardiomyopathy Ann. Thorac. Surg., May 1, 1999; 67(5): 1380 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Matsumoto, S.-i. Momomura, S. Sugiura, H. Fujita, T. Aoyagi, M. Sata, M. Omata, and Y. Hirata Effect of Inhaled Nitric Oxide on Gas Exchange in Patients with Congestive Heart Failure: A Randomized, Controlled Trial Ann Intern Med, January 5, 1999; 130(1): 40 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ishihara, J. A. Ward, O. Tasaki, B. A. Pruitt Jr., C. W. Goodwin Jr., D. W. Mozingo, and W. G. Cioffi Jr. Inhaled nitric oxide prevents left ventricular impairment during endotoxemia J Appl Physiol, December 1, 1998; 85(6): 2018 - 2024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. ZIEGLER, D. D. IVY, J. W. WIGGINS, J. P. KINSELLA, W. R. CLARKE, and S. H. ABMAN Effects of Dipyridamole and Inhaled Nitric Oxide in Pediatric Patients with Pulmonary Hypertension Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1388 - 1395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Argenziano, D. A. Dean, N. Moazami, D. J. Goldstein, E. A. Rose, H. M. Spotnitz, D. Burkhoff, M. C. Oz, and M. L. Dickstein Inhaled Nitric Oxide Is Not A Myocardial Depressant In A Porcine Model Of Heart Failure J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 700 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. G. Krohn and J. M. Hare Inhaled NO and Pulmonary Vasodilation • Response Circulation, January 27, 1998; 97(3): 292 - 292. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Goldstein, D. A. Dean, A. Smerling, M. C. Oz, D. Burkhoff, and M. L. Dickstein INHALED NITRIC OXIDE IS NOT A NEGATIVE INOTROPIC AGENT IN A PORCINE MODEL OF PULMONARY HYPERTENSION J. Thorac. Cardiovasc. Surg., September 1, 1997; 114(3): 461 - 466. [Abstract] [Full Text]
|
|
|
|
|
|
N. D. Hillman, I. M. Cheifetz, D. M. Craig, P. K. Smith, R. M. Ungerleider, and J. N. Meliones INHALED NITRIC OXIDE, RIGHT VENTRICULAR EFFICIENCY, AND PULMONARY VASCULAR MECHANICS: SELECTIVE VASODILATION OF SMALL PULMONARY VESSELS DURING HYPOXIC PULMONARY VASOCONSTRICTION J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 1006 - 1013. [Abstract] [Full Text]
|
|
|
|
|
|
J. M. Hare, S. K. Shernan, S. C. Body, E. Graydon, W. S. Colucci, and G. S. Couper Influence of Inhaled Nitric Oxide on Systemic Flow and Ventricular Filling Pressure in Patients Receiving Mechanical Circulatory Assistance Circulation, May 6, 1997; 95(9): 2250 - 2253. [Abstract] [Full Text]
|
|
|
|
|
|
M. P. Moya, A. J. Gow, T. J. McMahon, E. J. Toone, I. M. Cheifetz, R. N. Goldberg, and J. S. Stamler S-nitrosothiol repletion by an inhaled gas regulates pulmonary function PNAS, May 8, 2001; 98(10): 5792 - 5797. [Abstract] [Full Text] [PDF]
|
|